Sania Therapeutics, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Sania Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (May 2024).
SEC Form D · May 2024
The industry group it chose in its notices: Biotechnology.
SEC Form D · May 2024
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Sania Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Andrew Murray | Executive officer | May 2024 |
| Raj Dattani | Executive officer | Mar 2022 |
| Robert Brownstone | Executive officer | Mar 2022 |
| Andrew Murray | Director | May 2024 |
| Joseph Korff | Director | May 2024 |
| Mark Evans | Director | May 2024 |
| Robert Brownstone | Director | May 2024 |
| Raj Dattani | Director | Mar 2022 |